Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 2, 2008, Pages 266-274

  Riddle, Mark S ^a,b   Tribble, David R ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NONE   (United States)

Author keywords

Delphi survey; Travellers' diarrhoea; US military; Vaccine development

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH SALICYLATE; ESCHERICHIA COLI ENTEROTOXIN; LOPERAMIDE; VACCINE;

ACUTE DIARRHEA; ARMY; ARTICLE; BEHAVIOR; CAMPYLOBACTER; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DELPHI STUDY; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; INFECTIOUS DIARRHEA; LICENSING; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; NOROVIRUS; POPULATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SELF CARE; SHIGELLA; SOLDIER; TIME; TRAVEL; UNCERTAINTY; UNITED STATES;

DELPHI TECHNIQUE; DYSENTERY; HEALTH CARE SURVEYS; HUMANS; MILITARY PERSONNEL; TRAVEL; UNITED STATES; VACCINES;

EID: 40449122341     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00848.x     Document Type: Article

References (59)

1. Riddle, M. S., Sanders, J. W., Putnam, S. D. Tribble, D. R. (2006) Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. American Journal of Tropical Medicine and Hygiene, 74 (5 891 900.
2. Sanders, J. W., Putnam, S. D., Riddle, M. S. Tribble, D. R. (2005) Military importance of diarrhea: lessons from the Middle East. Current Opinions in Gastroenterology, 21 (1 9 14.
3. Sanders, J. W., Putnam, S. D., Frankart, C., Frenck, R. W., Monteville, M. R., Riddle, M. S., Rockabrand, D. M., Sharp, T. W. Tribble, D. R. (2005) Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan). American Journal of Tropical Medicine and Hygiene, 73 (4 713 719.
4. Sanders, J. W., Putnam, S. D., Riddle, M. S., Tribble, D. R., Jobanputra, N. K., Jones, J. J., Scott, D. A. Frenck, R. W. (2004) The epidemiology of self-reported diarrhea in operations Iraqi freedom and enduring freedom. Diagnostic Microbiology and Infectious Disease, 50 (2 89 93.
5. Putnam, S. D., Sanders, J. W., Tribble, D. R., Rockabrand, D. R., Riddle, M. S., Rozmajzl, P. J. Frenck, R. W. (2005) Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin. Antimicrobial Agents and Chemotherapy, 49 (6 2571 2572.
6. st century Washington, DC : US Department of Health and Human Services. Available from http://www.hhs.gov/nvpo/ nvac/vaccines21cer.html (accessed 31 January 2008).
7. Lemon, S. M., Thaul, S., Fisseha, S. O'Maonaigh, H. C. (2003) Protecting Our Forces: Improving Vaccine Acquisition and Availability in the US Military. IOM Report. Washington, DC : Institute of Medicine of the National Academies, 2003.
8. Sanders, J. W., Putnam, S. D., Gould, P. et al. (2005) Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001 - Egypt. Diagnostic Microbiology and Infectious Disease, 52 (2 85 90.
9. Sanders, J. W. (2005) Azithromycin and Loperamide Is Comparable to Levofloxacin and Loperamide for the Treatment of Traveler's Diarrhea in U.S. Military Personnel in Turkey. San Fransisco, CA : Infectious Disease Society of America.
10. Riddle, M. S., Tribble, D. R., Jobanputra, N. K., Jones, J. J., Putnam, S. D., Frenck, R. W. Sanders, J. W. (2005) Knowledge, attitudes, and practices regarding epidemiology and management of travelers' diarrhea: a survey of front-line providers in Iraq and Afghanistan. Military Medicine, 170 (6 492 495.
11. Sanders, J. W., Isenbarger, D. W., Walz, S. E., et al. (2002) An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. American Journal of Tropical Medicine and Hygiene, 67 (5 533 538.
12. Sanchez, J. L., Gelnett, J., Petruccelli, B. P., Defraites, R. F. Taylor, D. N. (1998) Diarrheal disease incidence and morbidity among United States military personnel during short-term missions overseas. American Journal of Tropical Medicine and Hygiene, 58 (3 299 304.
13. Murphy, G. S. Echeverria, P., Jackson, L. R., Arness, M. K., LeBron, C. Pitarangsi, C. (1996 Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. Clinical Infectious Diseases, 22 (5 868 869.
14. Hyams, K. C., Bourgeois, A. L., Merrell, B. R., et al. (1991) Diarrheal disease during Operation Desert Shield. New England Journal of Medicine, 325 (20 1423 1428.
15. Hasson, F., Keeney, S. McKenna, H. (2000) Research guidelines for the Delphi survey technique. Journal of Advanced Nursing, 32 (4 1008 1015.
16. Bowles, N. (1999) The Delphi technique. Nursing Standard, 13 (45 32 36.
17. Putnam, S. D., Sanders, J. W., Frenck, R. W., Monteville, M., Riddle, M. S., Rockabrand, D. M., Sharp, T. W., Frankart, C. Tribble, D. R. (2006) Self-reported description of diarrhea among military populations in operations Iraqi freedom and enduring freedom. Journal of Travel Medicine, 13 (2 92 99.
18. Girard, M. P., Steele, D., Chaignat, C. L. Kieny, M. P. (2006) A review of vaccine research and development: human enteric infections. Vaccine, 24 (15 2732 2750.
19. Nataro, J. P. (2004) Vaccines against diarrheal diseases. Seminars in Pediatric Infectious Diseases, 15 (4 272 279.
20. Wiedermann, G., Kollaritsch, H., Kundi, M., Svennerholm, A. M. Bjare, U. (2000) Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report). Journal of Travel Medicine, 7 (1 27 29.
21. Turner, A. K., Beavis, J. C., Stephens, J. C., Greenwood, J., et al. (2006) Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I. Infection and Immunity, 74 (2 1062 1071.
22. Katz, D. E., DeLorimier, A. J., Wolf, M. K., et al. (2003) Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine, 21 (5-6 341 346.
23. Guerena-Burgueno, F., Hall, E. R., Taylor, D. N., et al. (2002) Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infection and Immunity, 70 (4 1874 1880.
24. Oyofo, B. A., Subekti, D. S., Svennerholm, A. M., et al. (2001) Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia. American Journal of Tropical Medicine and Hygiene, 65 (2 120 124.
25. Qadri, F., Das, S. K., Faruque, A. S., Fuchs, G. J., Albert, M. J., Sack, R. B. Svennerholm, A. M. (2000) Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. Journal of Clinical Microbiology, 38 (1 27 31.
26. Jiang, Z. D., Lowe, B., Verenkar, M. P., Ashley, D., Steffen, R., Tornieporth, N., von Sonnenburg, F., Waiyaki, P. DuPont, H. L. (2002) Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). Journal of Infectious Diseases, 185 (4 497 502.
27. McKenzie, R., Walker, R. I., Nabors, G. S., et al. (2006) Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. Vaccine, 24 (18 3735 3745.
28. Passwell, J. H., Ashkenazi, S., Harlev, E., et al. (2003) Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children. Pediatric Infectious Disease Journal, 22 (8 701 706.
29. Passwell, J. H., Harlev, E., Ashkenazi, S., et al. (2001) Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infection and Immunity, 69 (3 1351 1357.
30. Fries, L. F., Montemarano, A. D., Mallett, C. P., Taylor, D. N., Hale, T. L. Lowell, G. H. (2001) Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infection and Immunity, 69 (7 4545 4553.
31. Walker, R. I. (1999) Campylobacter vaccine development: a key to controlling enteric diseases. Expert Opinion on Investigational Drugs, 8 (2 107 113.
32. Scott, D. A. (1997) Vaccines against Campylobacter jejuni. Journal of Infectious Diseases, 176 (Suppl. 2 S183 S188.
33. Cohen, D., Ashkenazi, S., Green, M. S., et al. (1997) Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. Lancet, 349 (9046 155 159.
34. Cohen, D., Ashkenazi, S., Green, M., et al. (1996) Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers. Infection and Immunity, 64 (10 4074 4077.
35. Katz, D. E., Coster, T. S., Wolf, M. K., et al. (2004) Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers. Infection and Immunity, 72 (2 923 930.
36. Kotloff, K. L., Taylor, D. N., Sztein, M. B., et al. (2002) Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults. Infection and Immunity, 70 (4 2016 2021.
37. Kotloff, K. L., Noriega, F. R., Samandari, T., Sztein, M. B., Losonsky, G. A., Nataro, J. P., Picking, W. D., Barry, E. M. Levine, M. M. (2000) Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infection and Immunity, 68 (3 1034 1039.
38. Kotloff, K. L., Noriega, F., Losonsky, G. A., Sztein, M. B., Wasserman, S. S., Nataro, J. P. Levine, M. M. (1996) Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infection and Immunity, 64 (11 4542 4548.
39. Cohen, D., Green, M. S., Block, C., Rouach, T. Ofek, I. (1988) Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. Journal of Infectious Diseases, 157 (5 1068 1071.
40. Cohen, D., Green, M. S., Block, C., Slepon, R. Ofek, I. (1991) Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. Journal of Clinical Microbiology, 29 (2 386 389.
41. Hartman, A. B., Powell, C. J., Schultz, C. L., Oaks, E. V. Eckels, K. H. (1991) Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infection and Immunity, 59 (11 4075 4083.
42. Venkatesan, M. M., Hartman, A. B., Newland, J. W., Ivanova, V. S., Hale, T. L., McDonough, M. Butterton, J. (2002) Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine. Infection and Immunity, 70 (6 2950 2958.
43. Tacket, C. O., Sztein, M. B., Losonsky, G. A., Wasserman, S. S. Estes, M. K. (2003) Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clinical Immunology, 108 (3 241 247.
44. Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M. Arntzen, C. J. (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. Journal of Infectious Diseases, 182 (1 302 305.
45. Ball, J. M., Graham, D. Y., Opekun, A. R., Gilger, M. A., Guerrero, R. A. Estes, M. K. (1999) Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology, 117 (1 40 48.
46. Johnson, P. C., Mathewson, J. J., DuPont, H. L. Greenberg, H. B. (1990) Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. Journal of Infectious Diseases, 161 (1 18 21.
47. Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J. Baric, R. (2003) Human susceptibility and resistance to Norwalk virus infection. Nature Medicine, 9 (5 548 553.
48. Centers for Disease Control and Prevention 2005) Health Information for International Travel 2005-2006. Atlanta : US Department of Health and Human Services, Public Health Service.
49. Marfin, A. A., Eidex, R. S., Kozarsky, P. E. Cetron, M. S. (2005) Yellow fever and Japanese encephalitis vaccines: indications and complications. Infectious Disease Clinics of North America, 19 (1 151 168, ix.
50. Wilson, M. E. (2001) Travel-related vaccines. Infectious Disease Clinics of North America, 15 (1 231 251.
51. Wiedermann, G., Kollaritsch, H., Jeschko, E., Kundi, M., Herzog, C. Wegmuller, B. (1998) Adverse events after oral vaccination against cholera with CVD103-HgR. Wiener Klinische Wochenschrift, 110 (10 376 378.
52. Engels, E. A., Falagas, M. E., Lau, J. Bennish, M. L. (1998) Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. British Medical Journal, 316 (7125 110 116.
53. Nothdurft, H. D., Jelinek, T., Marschang, A., Maiwald, H., Kapaun, A. Loscher, T. (1996) Adverse reactions to Japanese encephalitis vaccine in travellers. Journal of Infection, 32 (2 119 122.
54. Jones, J. Hunter, D. (1995) Consensus methods for medical and health services research. British Medical Journal, 311 (7001 376 380.
55. Sibbald, R. G., Torrance, G., Hux, M., Attard, C. Milkovich, N. (2003) Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers. Ostomy/Wound Management, 49 (11 76 84.
56. Cramer, C. K., Epstein, J. B., Sheps, S. B., Schechter, M. T. Busser, J. R. (2002) Modified Delphi survey for decision analysis for prophylaxis of post-radiation osteonecrosis. Oral Oncology, 38 (6 574 583.
57. Shadidi, K. R., Thompson, K. M., Henriksen, J. E., Natvig, J. B. Aarvak, T. (2002) Association of antigen specificity and migratory capacity of memory T cells in rheumatoid arthritis. Scandinavian Journal of Immunology, 55 (3 274 283.
58. Kirigia, J. M. (1997) Economic evaluation in schistosomiasis: using the Delphi technique to assess effectiveness. Acta Tropica, 64 (3-4 175 190.
59. Stratton K. R., Durch, J. S. Lawrence, R. S. (1999) Vaccines for the 21st Century: A Tool for Decision Making. IOM Report. Washington, DC : Institute of Medicine, National Academies.